In addition, GSK‐3β inhibitors were also effective in suppressing malignant cell proliferation,51 so many of them have also entered clinic trials for the treatment of advanced cancers (https://clinicaltrials.gov/ct2/show/NCT03678883?term=9-ing&rank=1). The gene discussed is GSK3B; the disease is cancer.